GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » Other Net Income (Loss)

Kingworld Medicines Group (HKSE:01110) Other Net Income (Loss) : HK$0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group Other Net Income (Loss)?

Kingworld Medicines Group's Other Net Income (Loss) for the six months ended in Dec. 2024 was HK$0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0 Mil.

Kingworld Medicines Group's quarterly Other Net Income (Loss) declined from Dec. 2023 (HK$0 Mil) to Jun. 2024 (HK$0 Mil) but then stayed the same from Jun. 2024 (HK$0 Mil) to Dec. 2024 (HK$0 Mil).

Kingworld Medicines Group's annual Other Net Income (Loss) declined from Dec. 2022 (HK$0 Mil) to Dec. 2023 (HK$-0 Mil) but then increased from Dec. 2023 (HK$-0 Mil) to Dec. 2024 (HK$0 Mil).


Kingworld Medicines Group Other Net Income (Loss) Historical Data

The historical data trend for Kingworld Medicines Group's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kingworld Medicines Group Other Net Income (Loss) Chart

Kingworld Medicines Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kingworld Medicines Group Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kingworld Medicines Group Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kingworld Medicines Group Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Kingworld Medicines Group Business Description

Traded in Other Exchanges
N/A
Address
198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.
Executives
Chan Lok San 2101 Beneficial owner
Zhao Li Sheng 2101 Beneficial owner
Tricor Trust (hong Kong) Limited 2301 Trustee
Sinopharm Capital Limited 2201 Interest of corporation controlled by you
Sinopharm Healthcare Fund L.p. 2101 Beneficial owner
Sun Hill Capital Investments Limited 2201 Interest of corporation controlled by you
Wu Aimin 2201 Interest of corporation controlled by you
Sun Hill Capital Investments Limited 2201 Interest of corporation controlled by you
Wu Aimin 2201 Interest of corporation controlled by you

Kingworld Medicines Group Headlines

No Headlines